<?xml version="1.0" encoding="UTF-8"?>
<p>However, no evidence indicating a higher risk of COVID-19 in patients under chronic treatment with immunosuppressive drugs has been reported, although several physicians have expressed concern [
 <xref rid="B92-ijms-21-03492" ref-type="bibr">92</xref>,
 <xref rid="B93-ijms-21-03492" ref-type="bibr">93</xref>]. We agree with the need of further investigation and propose a retrospective analysis to be performed as soon as possible on COVID-19 patients databases, to evaluate both the risk in individuals on immunosuppressive agents and, possibly, the effects of thiopurine analogs (or rather their prodrugs as azathioprine) on the outcome. Moreover, other similar therapeutic strategies have been proposed in vitro, i.e., alpha-interferon and cyclosporin [
 <xref rid="B94-ijms-21-03492" ref-type="bibr">94</xref>].
</p>
